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Abstract
A fundamental property of cell populations is their growth rate as well as the time needed for cell division and its variance.
The eukaryotic cell cycle progresses in an ordered sequence through the phases G1, S, G2, and M, and is regulated by
environmental cues and by intracellular checkpoints. Reflecting this regulatory complexity, the length of each phase varies
considerably in different kinds of cells but also among genetically and morphologically indistinguishable cells. This article
addresses the question of how to describe and quantify the mean and variance of the cell cycle phase lengths. A phase-
resolved cell cycle model is introduced assuming that phase completion times are distributed as delayed exponential
functions, capturing the observations that each realization of a cycle phase is variable in length and requires a minimal time.
In this model, the total cell cycle length is distributed as a delayed hypoexponential function that closely reproduces
empirical distributions. Analytic solutions are derived for the proportions of cells in each cycle phase in a population
growing under balanced growth and under specific non-stationary conditions. These solutions are then adapted to describe
conventional cell cycle kinetic assays based on pulse labelling with nucleoside analogs. The model fits well to data obtained
with two distinct proliferating cell lines labelled with a single bromodeoxiuridine pulse. However, whereas mean lengths are
precisely estimated for all phases, the respective variances remain uncertain. To overcome this limitation, a redesigned
experimental protocol is derived and validated in silico. The novelty is the timing of two consecutive pulses with distinct
nucleosides that enables accurate and precise estimation of both the mean and the variance of the length of all phases. The
proposed methodology to quantify the phase length distributions gives results potentially equivalent to those obtained
with modern phase-specific biosensor-based fluorescent imaging.
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Introduction
The cell cycle is one of the most fundamental processes in
biology. Through this process, a parental cell transmits to its two
daughter cells genetic and epigenetic information by accurately
replicating its DNA and evenly apportioning all nuclear and
extranuclear contents. The mechanism of cell cycle regulation is
tailored to ensure accurate cellular content replication, but seems
to be less constrained by how long it takes to complete this process
successfully. Several check points exist that ensure that chromo-
somes are faithfully copied and that the parental cell has enough
material in order to produce two viable isogenic daughter cells.
Meeting the conditions of each of these check points takes variable
time and delays the completion of the cell cycle. Yet, how long the
cells take on average to complete the cell cycle is an important
biological property. In unicellular organisms, the average inter-
mitotic time is a direct measurement of the organism’s fitness,
while in multicellular organisms, the regulation of the rate of cell
division is critical for development, stem cell maintenance, tissue
or organ homeostasis, wound healing, and immunity. The
temporal organization of the cell cycle is therefore under tight
regulation, likely reflecting a fine balance between accuracy in
information transmission and speed.
The average cell cycle time has been estimated at the
population level by measuring the growth curve of exponentially
proliferating cell cohorts, under conditions in which cells can be
counted and cell death is negligible compared to the population
wide growth rate. Under conditions in which cell counting is not
possible or in which cell death rates cannot be neglected (e.g.,
homeostasis, immune reactions, cancer growth), indirect estimates
for the average division time or the average death time are
typically inferred e.g., through the rate of increase of cells arrested
in mitosis after administration of colchicine, the fraction of labelled
mitotic figures after pulse labelling (FLM method), and from long-
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term labelling and delabelling time-series of deuterium or
bromodeoxyuridine (BrdU) tracing experiments [1–3]. For grow-
ing cell populations these estimates depend on assumptions about
the shape of the intermitotic time distribution [4]. The latter, when
analyzed at a single-cell level, e.g., by time-lapse imaging, shows
significant variability in otherwise seemingly homogeneous cell
populations. This observation led more than forty years ago to the
development of one of the first stochastic cell cycle models [5].
Smith and Martin proposed at that time that cell’s life
comprehends an A state and a B phase. Whereas the time cells
spend in the A state was assumed to be exponentially distributed,
the time cells spend in the B phase was, in this simplest scenario, a
fixed delay. Experimental validation was provided by time-lapse
imaging of growing cell cultures, measurements of fraction of
labelled mitoses and fractions of sibling pairs with age difference
greater than a specified value [6]. Even though later studies [7–10]
have shown that the model assumptions do not exactly match
experimental data, its simplicity and mathematical tractability
makes the Smith-Martin model even today a popular theoretical
model [6,11].
In the last ten years, 5-(and 6)-Carboxyfluorescein diacetate
succinimidyl ester (CFSE) dilution assays in concert with a whole
set of advanced modeling techniques [12–14] allowed to estimate
the average duration, as well as inter-cellular variability in more
complex scenarios with division time densities in vitro or in vivo
after adoptive cell transfer. Especially generation structure,
activation times and generation dependent cell death were
included in these models and subsequently estimated in the
context of lymphocyte proliferation. Inter-cellular variability not
only of division times but also of death times were confirmed
directly in long-term tracking of single HeLa cells [15] and B-
lymphocytes [10]. The latter study provided extensive quantitative
data on the shape of age-dependent division and death time
distributions which are required to calibrate e.g., the Cyton [16] or
similar models. A review on these, and alternative stochastic cell
cycle models is given in [4].
At a higher temporal and functional resolution the eukaryotic
cell cycle is structured into four distinct phases: 1) the G1 phase
during which organelles are reorganized and chromatin is licensed
for replication, 2) the S phase in which the chromosomes are
duplicated by DNA replication, 3) the G2 phase which serves as a
holding time for synthesis and accumulation of proteins needed in
4) the M phase, or mitosis, which is marked by chromatin
condensation, nuclear envelope breakdown, chromosomal segre-
gation, and finally cytokinesis, which completes the generation of
two daughter cells in G1 phase [17].
Considering explicitly cell cycle phases in mathematical
models of cell division probably dates back to the discovery
that DNA is replicated mainly during a specific period of the
cell cycle. Already in their seminal paper, Smith and Martin
related the A state to the G1 phase and the B phase to the S, G2,
M and possibly to some part of the G1 phase. Subsequent
studies that explored phase-resolved cell cycle models, major-
itarely rooted in the field of oncology and cancer therapy,
include [18–25]. As in the present work, most of these studies
relied on flow cytometry (FACS) data generated by labelling
selectively cells that are synthesizing DNA using nucleoside
analogs (e.g., BrdU, iodo-deoxyuridine (IdU) or ethynyl-
deoxyuridine (EdU)), together with a fluorescent intercalating
agent to measure total DNA content (e.g., 4,6- diamidino-2-
phenylindole (DAPI), and propidium iodide (PI)), in order to test
the model assumptions and draw conclusions about the cells and
conditions under consideration.
Here we present a simple stochastic cell cycle model that
incorporates temporal variability at the level of individual cell
cycle phases. More precisely, we extend the concept underlying
the Smith-Martin model of delayed exponential waiting times to
the cell cycle phases. We first demonstrate that the model is in
good agreement with published experimental data on inter-mitotic
division time distributions. We then show, based on stability
analysis, that phase-specific variability remains largely undeter-
mined when measurements are taken on cell populations under
balanced growth (i.e., growth under asymptotic conditions in
which the expected proportions of cells in each phase of the
cycle are constant). We prove that by properly measuring
proliferating cells under unbalanced growth, one can with at
least three well placed support points, assuming noise-free
conditions, uniquely identify the average and variance in the
completion time of each of the cell cycle phases. When
comparing our model with two experimental data sets obtained
from conventional pulse-labelling experiments of distinct pro-
liferating cell lines, we find that, while the kinetics extracted
from these experiments are well approximated by the predic-
tions of the proposed model, the information content is
insufficient to determine accurately all the parameters. Finally
we propose a modification of the prevailing experimental
protocol, based on dual-pulse labelling with BrdU and, for
example, EdU, that overcomes this shortcoming.
Results
Model definition
The eukaryotic cell cycle is defined as an orderly sequence of
three phases distinguished by cellular DNA content, termed G1, S
and G2M: A dividing cell is supposed to proceed, under this
minimalist view, from one phase to another in a fixed order, until
reaching the end of G2M phase. Here it completes cytokinesis
generating two genetically identical daughter cells that are by
definition in G1 phase (Fig. 1 A). We assume that the completion
time of any phase (i.e. the time lapse between the entry to and exit
from that given phase) is a random variable t, which is distributed
according to a delayed (or shifted) exponential density function
(Fig. 1 B),
Author Summary
Among the important characteristics of dividing cell
populations is the time necessary for cells to complete
each of the cell cycle phases, that is, to increase the cell’s
mass, to duplicate and repair its genome, to properly
segregate its chromosomes, and to make decisions
whether to continue dividing or enter a quiescent state.
The cycle phase times also determine the maximal rate at
which a dividing cell population can grow in size. Cell cycle
phase completion times largely differ between cell types,
cellular environments as well as metabolic stages, and can
thus be considered as part of the phenotype of a given
cell. Our article advances the methods to quantitatively
characterize this phenotype. We introduce a novel phase-
resolved cell cycle progression model and use it to
estimate the mean and variance of the cycle phase
completion times based on nucleoside analog pulse
labelling experiments. This classic workhorse of cell cycle
kinetic studies is revamped by our approach to potentially
rival in accuracy and precision with modern phase-specific
biosensor-based fluorescent imaging, while superseding
the latter in its application scope.
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ft(t)~
1
a
e{
1
a(t{b)H(t{b), ð1Þ
where a is the reciprocal of the rate of the exponential (measured
in time units) and b is the fixed delay (in time units), and H
denotes the Heaviside step function whose value is zero for
negative argument, i.e., for tvb, and one for positive argument.
Notice that with a slight abuse of notation we denote here the
random variable (subscript of density function f ) and the value it
assumes (the argument of the function ft) by the same symbol t:
This will allow us to denote the probability density function and
the cumulative probability distribution of the random variable x
by fx and Fx respectively, and to define the complementary
cumulative distribution Rx~1{Fx: The delay b in Eq. 1 ‘ensures’
that a cell that enters a specific phase will remain therein for at
least b time units (e.g. hours) before proceeding to the next phase.
Besides this fixed minimal time b, additional less predictable
effects that affect the completion of the processes associated to a
phase are assumed to be exponentially distributed with both mean
and standard deviation given by a: The phase specific mean
completion time, denoted in the following by t is then azb with
standard deviation a and coefficient of variation a=t: The Laplace
transform of Eq. 1 is given by
Lv ft(t)f g~ e
{bv
1zav
, ð2Þ
where v is the transformed variable corresponding to the time
lapse t: The temporal organization of the cell cycle is defined by
the vector of phase-specific completion times, t~ftG1 ,tS,tG2Mg,
which in turn depend on the parameter vectors a~faG1 ,aS,aG2Mg
and b~fbG1 ,bS,bG2Mg: The cell cycle length, understood as the
time lapse between the entry into G1 until exit out of G2M, is the
random variable T~tG1ztSztG2M: Its probability density
function is the convolution of the three underlying delayed
exponential distributions and corresponds to the delayed hypoex-
ponential distribution. Explicit expressions can be computed using
the inverse Laplace transform L{1 of the product of the Laplace
transforms of the three densities given by Eq. 2, i.e.,
fT (T)~L{1T P
i
e{biv
1zaiv
 
with i~G1, S, G2M: ð3Þ
In case that all entries in a are distinct, we get
fT (T)~
X
i
ai e
{
(T{B)
ai
Pj, i=j (ai{aj)
0
B@
1
CAH T{Bð Þ, ð4Þ
in which the indices i and j iterate over the three phases and B is
the sum of the elements in b:
In Fig. 1 B we plot the shape of the phase specific completion
time distribution ft defined by Eq. 1, which illustrates that the
probability for a cell to complete a given phase in less than b time
units is zero under this model. A graphical representation of the
cell cycle model is provided in Fig. 1 A. Notice that each phase can
have distinct parameter values a and b for the completion time
distribution.
As a first validation, we compared the empirical frequency of
undivided cells as a function of time after ‘birth’ (reported by [5])
with the respective probability according to the model 1{FT ,
which we denote as RT (Fig. 1 C). As a second test, we fitted the
cell cycle length density fT given by Eq. 4 to data extracted from
video-tracking of in vitro proliferating B cells [10]. The delayed
hypoexponential distribution fT (shown in Fig. 1 D), but also the
delayed log-normal and the delayed gamma distribution (not
shown) with parameter values proposed in [10], reproduce closely
the measured division time histogram. While the two latter depend
on three parameters each, the hypoexponential distribution
depends on six parameters, that remain largely undetermined
given this kind of data.
Balanced growth
A proliferating cell population that obeys the probability model
specified in the previous section can be represented by a non-
Markov multidimensional random process, whose evolution
depends on its history. There exist an infinite number of possible
histories or realizations of the population size dynamics N(t): We
focus here on a specific important subset, namely those under
balanced growth. Under balanced growth a cell population grows
exponentially E½N(t)~def E½NG1(t)zNS(t)zNG2M(t)!emt with
mean growth rate m and constant mean proportions of cells in
the three phases n~fnG1 ,nS,nG2Mg, where e.g.,
nG1~
def
E½NG1(t)=(NG1(t)zNS(t)zNG2M(t)): The expectation
operator E½ is defined over all possible realizations of the process.
We will now derive explicit expressions for nG1 , nS and nG2M
and a transcendental equation that defines m, the growth rate. A
Figure 1. Stochastic cell cycle model. A: Scheme of the proposed
cell cycle model with three phases G1, S and G2M: The dashed border
between the G2 and the M phase indicates that the G2 and M phase
are pooled into a single phase. The random time t a cell needs to
complete the processes associated to each of the phases, follows a
delayed exponential distribution with specific parameters a and b for
each phase. B: Delayed-exponential completion time distribution
density ft with parameters a and b: C: Best fit of the complementary
cumulative distribution RT to the fraction of undivided cells after birth
obtained by time lapse cinematography [5] of slow and fast dividing
cell lines. D: Best fit of fT defined by Eq. 4 (solid line) to inter-mitotic
time distribution density measured by long-term video tracking of in
vitro proliferating B-cells [10]. The data in C and D were read from the
graphs in the original publications ([5] and [10] respectively).
doi:10.1371/journal.pcbi.1003616.g001
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first step in obtaining the constant frequencies of cells in each of
the phases consist in computing the ratio between the cells that
complete a given phase and the total number of cells inside the
same phase at time t: This phase-specific quantity, denoted here
by c, represents the asymptotic efflux rate constant, which will be
useful, as we will see, to construct a transition probability matrix
Q: The latter will enable us to employ methods from linear algebra
to solve the steady state condition.
Suppose for example that a cohort of cells entered a given phase
at time tin: Then the density of cells leaving this phase at time tout
will be ft(tout{tin): Similarly if a cohort of cells entered this phase
at time tin, then a proportion Rt(t{tin) will remain in it until time
t:
Recalling that the influx of cells into a given phase is
proportional to em t and that Rt(t) is the complementary
cumulative distribution of t, (1{Ft(t)), which is Laplace
transformed to Lvf1{Ft(t)g~(1{Lvfft(t)g)=v, we integrate
over all past entries and finally take the ratio to obtain
c~
Ð t
{? e
mxft(t{x)dxÐ t
{? e
mxRt(t{x)dx
ð5Þ
~
mLmfft(t)g
1{Lmfft(t)g ð6Þ
~
m
(amz1)ebm{1
: ð7Þ
While the second equality is a consequence of the definition of
the Laplace transform, the third equality follows by substituting
Lmfft(t)g using Eq. 2. For a phase without a delay, i.e., b~0, the
last expression simplifies to the familiar mass action principle,
where the transition probability is directly proportional to the
decay rate 1=a: Assuming that cells are immortal and recalling
that division occurs as cells proceed from G2M to G1 we build up
the transition probability matrix as follows
Q~
{cG1 0 2cG2M
cG1 {cS 0
0 cS {cG2M
2
64
3
75: ð8Þ
The balanced growth condition can now be formulated in
matrix form
Q
nG1
nS
nG2M
2
64
3
75~m
nG1
nS
nG2M
2
64
3
75, ð9Þ
where the growth rate m is an eigenvalue of Q and the
proportions vector n~fnG1 , nS, nG2Mg is the corresponding
eigenvector. It can be shown that there exists a single dominating
real positive eigenvalue for Q (see Materials and Methods) whose
associated normalized eigenvector is
nG1
nS
nG2M
2
64
3
75~
2|(1{1=(e
bG1
m
(aG1mz1)))
1{nG1{nG2M
{1|(1{e
bG2M
m
(aG2Mmz1))
2
664
3
775: ð10Þ
The uniqueness and existence of a dominating positive real root
ultimately motivates our focus on balanced exponential growth, as
any immortal proliferating cell population with sufficient nutrients
and space will eventually enter this stationary phase. The time it
takes, either starting with a single cell or a synchronized cell cohort
to enter this state depends on the cell cycle parameters. The
exponential growth rate m is the unique real positive root of the
characteristic equation det(Q{m1)~0 which writes as
m3(2{Pi ebim(1zaim))
Pi (ebim(1zaim){1)
~0: ð11Þ
It is easy to see that the denominator in Eq. 11 is always
positive. To determine a non-trivial m it remains to solve the
transcendental equation in the numerator
2{P
i
ebim(1zaim)~0: ð12Þ
Numerical solutions to this equation can be computed using
e.g., the Newton-Raphson root finding algorithm, with fast
convergence if the initial value is set to m0~ log (2)=T , where T
is the average cell cycle length, i.e., the sum of the elements in
t~ftG1 ,tS,tG2Mg: This first guess is a naive estimate for m
assuming that cells divide according to a deterministic division
time identical to the average of the hypoexponential density
defined in Eq. 3.
Learning from cell frequencies measured under balanced
growth
The predicted fractions of cells in each of the phases can be
compared to frequencies extracted experimentally from bivariate
analysis of cell populations transiently exposed to nucleoside
analogs and subsequently examined both for the intensities of the
signals due to incorporated nucleoside analog and total DNA
content [26] (e.g. the so called BrdU-DAPI staining dot plot). The
question that we want to address in this section is: What can
potentially be learned about the parameters of the model, given
this type of experimental data? By definition, the measured
frequencies will sum to one, and therefore we have for three
populations effectively only two equations but six model param-
eters. This makes it impossible to identify all the parameter values,
irrespective of the number of samples we take. It is however
possible to derive analytical expressions for the upper and lower
bounds for both the parameters and the average completion time
of each phase.
Consider the experimentally determined frequencies, denoted
by ~n~f~nG1 , ~nS, ~nG2Mg: Substituting the vector n by ~n in Eq. 10
and solving for each phase specific parameter a, we obtain
a~(ke{bm{1)=m, ð13Þ
A Stochastic Phase-Resolved Cell Cycle Model
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where k is a phase specific element of the vector
k~ kG1 ,kS,kG2M
n o
~
2
2{~nG1
,
2{~nG1
1z~nG2M
, 1z~nG2M
( )
: ð14Þ
The phase specific parameters a and b, respectively the
reciprocal rate and delay, are by definition greater or equal to
zero. These conditions propagate into Eq. 13 which allows us to
specify boundaries for a and b: First notice that a is, for each
phase, a monotonically decreasing function of b with a maximum
(k{1)=m at b~0 and a zero crossing at b~ ln (k)=m: The
maximum and the root represent the upper bounds for a and b
respectively, while the lower bounds are zero for both. We thus
have for each phase
a[ 0, (k{1)=m½  and b[ 0, ln (k)=m½ : ð15Þ
The mean phase-specific completion time, t, the sum of the
reciprocal rate a and the delay b, is also bounded, with an interval
given by
t~(azb) [ ln (k)=m, (k{1)=m½ : ð16Þ
This result is derived from the fact that (azb) is concave having
its unique minimum at b~ln(k)=m, which follows from setting the
derivative Lb(azb)~1{ke{bm to zero. This implies that (azb)
is a monotonically decreasing function in the interval
b [ ½0, ln (k)=m with the corresponding extrema specified above.
It is important to note that the intervals defined by Eqs 13–16
depend on the average growth rate m which is in general not
known. Formally if one specific pair of parameter vectors a and b
explains the measured frequencies with growth rate m, the scaled
parameter vectors ca and cb mimic equally well the same data for
arbitrary positive c, however with a reduced growth rate m=c: This
can be easily verified by substituting these expressions in Eq. 10
and Eq. 12. The direct consequence is that m remains undefined.
However for the relative average time a cells spends e.g., in G1
phase (aG1zbG1)=T the growth rate cancels out.
Using the fact that k[1,2½ and the appropriate series expansion
for the natural logarithm, the widths of the intervals bounding a, b
and (azb) for each phase can be written as:
wa~
1
m
(k{1)~
1
m
X1
i~1
({1)iz1
i
(k{1)i,
wb~
1
m
X?
i~1
({1)iz1
i
(k{1)n, ð17Þ
wazb~
1
m
X?
i~2
({1)i
i
(k{1)n:
From this it is straight-forward to show that wawwbwwazb:
This implies that by using measurements of the phase-specific
stationary cell frequencies to infer the phase-specific completion
times t results in estimates of the mean value azb that are more
precise than the estimates of the standard deviation a: Notice that
the width of the intervals can be interpreted as a naive lower
bound for the uncertainty about the respective parameter values.
For the two data sets analyzed in this article (see details in next
section), we computed the intervals for the phase-specific standard
deviations wa that were on average *10 times wider than the
intervals for the expected phase-specific completion times wazb:
Transient unbalanced growth
Balanced growth analysis does not allow to distinguish between fixed
(a~0) and purely exponentially distributed (b~0) completion times
even if m is known. This follows from Eq. 15 because possible values for
the standard deviation a include 0 and (k{1)=m, and the latter
requires, according to Eq. 16, the delay b to be null.
The incapacity to resolve the values of a and b is overcome if
one selects and follows a subpopulation within which the
proportions of cells in each phase are transiently different from
the balanced growth proportions. Consider a simple thought
experiment that consists in taking a population under balanced
growth and labelling all the cells that are in a specific phase, say o,
which can be either G1, S or G2M: Initially all the cells are in the
same phase o, but as time passes by the labelled cells progress
through the cell cycle and eventually distribute over the three
phases. The labelled cell subpopulation which is initially not
balanced will return asymptotically to balanced growth conditions,
restoring the corresponding proportions of cells in the three
phases. We refer to this transient dynamics of a selected
subpopulation as transient unbalanced growth. It turns out that
measuring the transient dynamics of this subpopulation yields
information that potentially allows to distinguish between a fixed
and a purely exponentially distributed phase completion time.
More specifically, a mathematical proof will show that taking
samples at three well chosen time points (support points) permits
under ideal conditions accurate estimation of the average and the
variability in the time required to complete the phase o:
The initial average fraction of cells in phase o which are
selectively labelled at time t0 is determined by Eq. 10. To predict
when the labelled cells will have completed o, we need to specify
when they entered this phase. For the time before labelling the
average influx into o is proportional to emt. For the time after the
labelling, because by definition all labelled cells entered phase o
before t0 (otherwise they would not be labelled ‘as being in phase
o’), the entry of cells is zero. Hence, the average influx to the
labelled subpopulation is proportional to H(t0{t)e
m t, where H
denotes the Heaviside step function. Let us assume that within the
subpopulation of labelled cells and their progeny one could
identify how many phases a cell or a cohort of cells went through
since the labelling event, and let P count the number of phases
since labelling.
In close analogy to expression Eq. 5 we compute the time-
dependent exit-rate density distribution for cells with P~0 as
co
0?1
(t)~
Ð t
{?H(t0{x)e
mxfto (t{x)dxÐ t0
{?H(t0{x)e
mxRto (t0{x)dx
~
Ð t0
{? e
mxfto (t{x)dxÐ t0
{? e
mxRto (t0{x)dx
~
mLmffto (tzt)g
1{Lmffto (t)g
for t0~0:
ð18Þ
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where, for convenience, we interpreted and will interpret in the
following o both as a phase and a phase index. As before, the third
row follows from the definition of the Laplace transform setting
t0~0:. On the left-hand side, the arrow from 0 to 1 represents the
transition from the initial phase o (P~0) to the next phase (P~1),
corresponding to the completion of the initial phase o: In contrast
to Eq. 5, the denominator accounts for the cells that entered or
initiated phase o sometime in the past, and did not complete this
phase until the instant of labelling t0 (and not at time t as in Eq. 5),
while the numerator, except for the altered average influx, remains
unchanged.
After computing Lmfft(tzt)g and substituting Lmfft(t)g using
Eq. 2, Eq. 18 yields for twt0
co
0?1
(t)~
mem(t{t0)
(aomz1)ebom{1
tvt0zbo
me
bozaobom{tzt0
ao
(aomz1)ebom{1
t§t0zbo
0
BBBBB@ : ð19Þ
It follows that the accumulated average cell flux that at time t
has completed o and progressed to the next phase is given by
Co
0?1
(t)~
ðt
t0
co
0?1
(x)dx, ð20Þ
which for t?? approaches one, reflecting the fact that all cells
will eventually complete o:
The Laplace transform of Eq. 20 writes as
Lv Co
0?1
(t)
n o
~
mz aovm{ me
bo(m{v)(1zaom)
v(ebom(1z aom){1) (v{ m) (1z aov)
,
where v is, as before, the transformed variable corresponding to
t:
Within a cohort of cells isolated for instance in S phase, i.e.,
o~S, the accumulated average cell flux out of the subsequent
G2M phase can then be derived recalling Eq. 2 and using the
properties of the inverse Laplace transform as
CS
1?2
(t)~L{1t Lv CS0?1 (t)
n o
|
e
{bG2M
v
1zaG2Mv
( )
: ð21Þ
For an arbitrary cell cohort originally in o, the accumulated
average flux, completing P phases and entering the (Pz1)th phase
since isolation, can be written in general as
Co
P?Pz1
(t)~L{1t Lv C o0?1 (t)
n o
|P
P
p~1
e
{bq(o,p)v
1zaq(o,p)v
( )
, ð22Þ
in which q(o,p) denotes a function which returns an appropriate
phase index. For p[N and o[fG1, S, G2Mg it is defined as
q(o,p)~
def
w0z(pmod3) if o~G1
w1z(pmod3) if o~S
w2z(pmod3) if o~G2M
0
B@ ,
where mod is the modulo operation, and w~fG1, S, G2Mg is
a vector of cell cycle phase indices. The function q(o,p) thus
returns, for increasing p, in a cyclical fashion, the cell cycle phase
indices, starting with o for p~0: Notice that Eq. 21 corresponds to
Eq. 22 for o~S and P~1:
Analytical expression for Eq. 22, although solved relatively
easily with modern algebra software, can become quite cumber-
some for values of P larger than six. In our case, deriving the
expressions for p up to a value of five was sufficient to simulate the
experiments.
Because we want to compare the model predictions with
experimentally measured cell frequencies, more interesting than
the accumulated fluxes are the expected proportions of cells inside
each phase over time. These can be computed using Eqs 20–22,
closely following the methodology outlined in [11,12]. For the
fraction of cells initially in phase o we have
no0(t)~
no
em t
|(1{Co
0?1
(t)), ð23Þ
where the lower index 0 in no0(t) indicates that this expression
describes cells which completed zero phases since t0: The first term
on the right hand side corresponds to the fraction of cells in phase
o at t0 divided by e
m t, which accounts for the total population
growth during the same interval. The second term stands for the
fraction of cells that remained in phase o up to time t relative to
the initial number of cells in this phase. By evaluating the integral
in Eq. 20, substituting in Eq. 23 and letting as before, without loss
of generality, the time of partition t0 be zero, we get for tw0
no0(t)~
no
emt
|
1z
1{emt
(1zaom)ebom{1
tv bo
aome
bozaobom{t
ao
(1zaom)ebom{1
t§ bo
0
BBBB@ : ð24Þ
Expressions for cells initially in S, G1 or G2M phase can be
obtained by substituting o by the respective phase.
If there were no cell division (i.e., m~0) we could readily obtain
the average fraction of cells that completed P phases at time t as
the difference between the cells that entered the Pth phase, i.e.,
C
P{1?P (t), and those that left it, i.e., CP?Pz1 (t), divided by e
m t: To
account for cell division, we need to multiply this difference by an
additional term loP, which increases by a factor 2 each time cell
cohorts make a transition from G2M?G1: This term is defined,
for each case, as follows: lG1P ~2
tp
3
s, lSP~2
tpz1
3
s and lG2MP ~2
tpz2
3
s,
where the brackets in the exponent represent the floor operator.
In general we get for all consecutive phases for cells initially in
phase o the relatively manageable expression
nop(t)~
lop|n
o
em t
|(Co
(P{1)?P
(t){Co
P?(Pz1)
(t)): ð25Þ
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As for Eq. 24, the resulting solutions are defined as piecewise-
continuous functions in time. Also notice that most expressions in
this section can be written in more compact, but less intuitive,
vector form, by dropping the initial phase index o and using bold
vector notation as before.
Learning from cell frequencies measured in transiently
unbalanced growing subpopulations
In this section we will show that data from the transient kinetics
generated by our thought experiment allows to accurately estimate
the average and the variability in the individual completion times.
The proof is based on the analytical expressions derived in the
previous section, and also on the assumption that the kinetics are
acquired under the ideal conditions of large population sizes and
no measurement errors. The latter condition, although clearly
unrealistic, can always be approached in practice by increasing the
number of samples at each support point.
For the sake of generality, consider a subpopulation of cells
that are in an arbitrary phase and are labelled at t0~0:
Assuming that the ‘label’ does not in any way affect the cell
cycle of the cells, the parameters a and b of the labelled
subpopulation are the same as those of the full population under
balanced growth. Under these conditions, we can obtain a using
Eq. 13 and Eq. 14 with the fractions ~n of the full population
observed at time t0: Substituting a in the upper row of Eq. 24
and solving for m to find
m~
log (k~n ){ log ~nz(k{1)~n0(t0,b½)
 
t0, b½
, ð26Þ
where t0, b½ denotes an arbitrary time point that lies in the
interval 0,b½, ~n ~~n 0(0) and ~n 0(t) is the experimentally
determined equivalent of Eq. 24. This shows that the balanced
growth rate m is fully determined by only two support points, one
immediately after the partition at t~0 and a second at an
arbitrary t0, b½: This also makes clear that placing more support
points in the interval t0,b½ does not increase knowledge about m
nor the parameter values, under ideal conditions. Importantly the
uncertainty about the phase-specific variability discussed in
previous sections remains.
By replacing the same expression for a in the second row of the
right-hand side of Eq. 24 we get
~n 0(t½b,?)~
~n e
(
k m t½b,?{b m exp (bm)
exp bmð Þ{k )
(k{1)=(k{ exp bmð Þ) : ð27Þ
After experimentally acquiring m and the phase specific k and
~n 0(t½b,?), this expression will depend on a single unknown b:
One can show that Eq. 27 is solved by a unique b: This follows
from the fact that the right hand side of Eq. 27 is a monotonically
decreasing function in b[½0, ln (k)=m with corresponding values
lying in the interval ½~n exp ({k m t½b,?
k
{1),0 while the left hand
side is positive by definition. Substituting the solution for b into
Eq. 13 yields the remaining parameter vector a:
Taken together this proves that in theory samples of the three
cell cohorts G1, S and G2M taken at three support points, a first at
t~0, a second at 0vtvmin (b) and a third at twmax (b) are
sufficient to determine all the parameters of the model.
Conventional single pulse-labelling assays
The thought experiment analyzed so far, although conceptually
simple, poses a series of experimental challenges, that make a one-
to-one realization difficult. The technical difficulties lie mostly in
initially separating the cells according to their phase and in
following these cells as they enter the subsequent phases. A widely
used technique, namely DNA-nucleoside-analog pulse-chase
labelling experiments, generates nevertheless to a certain extent
Figure 2. DAPI-BrdU pulse-chase labelling FACS data. Samples taken at several time points after pulse labelling proliferating U87 human
glioblastoma cells with BrdU: The four gated populations are f lu, fuG2M, f
u
G1
and f ld which are defined precisely in the main text. Briefly, the subscript
indicates the phase at the instant of labelling, while the superscripts ‘u’, ‘lu’ and ‘ld’ refers to cells ‘unlabelled’, ‘labelled and undivided’ and ‘labelled
and divided’, respectively. The data was generated as described in the Experimental Methods section.
doi:10.1371/journal.pcbi.1003616.g002
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comparable data. The latter achieves the initial phase-specific
partitioning by exposing during a short time window proliferating
cells with a nucleoside analog (e.g., BrdU, IdU or EdU) that gets
selectively incorporated into the DNA of cells that are actively
replicating their genome. Measuring subsequently by FACS
simultaneously the DNA content and the amount of incorporated
nucleoside analog per cell permits to discern the three phases G1,
S and G2M immediately after the pulse. In addition, due to the
permanent staining property of the nucleoside analogs, it is
possible to follow, up to a certain degree, the labelled and
unlabelled cell cohorts over time. Several dies, such as Hoechst
33342, the dihydroanthraquinone analog DRAQ5, DAPI, and PI
are commonly available to stain DNA content in cells [27], and
can be used in combination with nucleotide analogs.
In theory, this method would largely correspond to the
hypothetical experiment that we analyzed so far. In practice
however, the overlap of the subpopulations in the FACS scatter
plots prevents the exact determination of the frequencies of cells
described by Eq. 24 and Eq. 25. For example labelled cells that
have completed the S phase but remain in G2M phase are
indistinguishable from those that did not complete the initial S
phase yet. As has been reported previously, only four different sub-
populations can be identified with reasonable accuracy [26].
These are:
N f lu: labelled undivided cells which at time of labelling (t0) were
in S phase (nS0zn
S
1 )
N fuG2M: unlabelled cells that were in G2M phase at t0 (nG2M0 )
N f ld: first generation progeny of labelled cells which were
initially in S phase (
P4
p~2 n
S
p )
N fuG1 : unlabelled cells and progeny of cells that were in G1 at t0
accompan ied by t he progeny o f fuG2M a nd f
ld
(1{flu{fuG2M{f
ld)
where the corresponding populations in our thought experiment
are indicated in brackets. This shows that computing Eq. 25 up to
p~4 is sufficient to describe a complete in silico BrdU pulse
labelling experiment. The reason is that, using current protocols,
fluorescence of labelled cells becomes indistinguishable from
background as soon as the cells divide a second time. In other
words, cells that leave population f ld by dividing a second time join
population fuG1 (see Fig. 2). For the experimental data, analyzed in
the next section, the fraction of labelled cells that completed two
cell divisions during the 12 hours time frame of the experiment is
negligible.
The population fuG2M is the only sub-population that matches
directly the type of data considered before and its temporal
evolution follows as such Eq. 24. The remaining three populations
in contrast represent mixtures of cell cohorts whose kinetics could
be described individually by Eqs 24–25.
Learning from single pulse-labelling data
By analyzing two data sets from samples of BrdU single pulse-
labelling experiments, we tested the model and the effect of
population intermixing on the identification of the model
parameter values. The two cell lines considered were in vitro
cultured U87 human glioblastoma cancer cells (for details see
Materials and Methods) and in vitro cultured V79 Chinese
hamster cells (courtesy G. Wilson). We will refer to these data as
the U87 and the V79 data sets. Both data sets consist of samples
taken from asynchronously dividing cell populations at several
time points after a single BrdU pulse, with sample sizes ranging
from 5000 to 50000 cells each. Data points represent
simultaneous measurements of BrdU as well as DAPI or PI
(DNA content) in a single cell by fluorescent activated cell
sorting.
As a preliminary test we minimized the residual sum of squares
(RSS), i.e., least-squares fitting, of adequate mixtures of Eq. 24
and Eq. 25 to extracted frequencies at different time points after
the pulse. We found that, for properly chosen parameter values,
both data sets were reasonably well approximated by the model
predictions (Fig. 3 A).
While this indicated that the model captured some of the
relevant temporal characteristics of cell cycle progression, a
subsequent analysis revealed that an infinite number of different
parameter combinations fitted the measured frequencies with the
same minimal RSS (not shown). This implies that there exist,
given the available data, no single best-fit parameter combination,
but a whole region in parameter space that can explain the data
equally well.
When we then interrogated the same data by approximate
maximum likelihood (ML) estimation, using a simple ad hoc
likelihood function (see Materials and Methods), we found again
Figure 3. Model based parameter estimation. A: Best fit of the
model predictions (lines) to experimentally determined cell fractions
after BrdU pulse labelling (dots). U87: In vitro cultured U87 human
glioblastoma cancer cell line (three replicates). V79: In vitro cultured V79
Chinese hamster cells (single replicate) (courtesy G. Wilson). Best fit
parameter values used to compute model predict ions
(U87: a~f3:2,3:9,3:4g,b~f5:7,4:1,2:1g, V79: a~f1:6,1:1,0:5g,b~
f1:4,7:8,1:9g, units are hours). B: Approximate ML regions for the
parameters a and b associated to each phase (gray: G1, red: S, green:
G2M). C: Bayesian bi-variate 99%-credibility regions for the parameters
a and b for each phase. Arrows indicate point estimates and the dashed
lines delineate the information that could have been gained in our
thought experiment under noise-free conditions from two support
points, one at t~0 and a second at tvmin (b). The U87 data set was
generated as described in the Experimental Methods section. The V79
data set was a kind gift of G. Wilson.
doi:10.1371/journal.pcbi.1003616.g003
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that relative large regions in parameter space mapped to the same
ML (see Fig. 3 B). It turned out that these regions were entirely
superimposed onto the lines defined by Eq. 13 and Eq. 26 (dashed
lines). These lines define what could have potentially been learned
in our thought experiment with only two support points, one at
t~0 and a second at tvmin (b). In both experiments, ML
parameters associated with the G1 phase were spread out almost
everywhere along these lines (Fig. 3 B, gray regions). Parameters
related to the S phase were more concentrated but still in the case
of the V79 data a substantial region of ML estimates were
observed. Finally the region for the G2M phase parameters
approached that of a point estimate for both data sets.
The spread of the ML estimates suggests that even in the ideal
case of large population size and noise-free data, the specific
choice of the support points in these experiments does not allow to
determine uniquely neither the delay nor the standard deviation
for all the phases. In contrast the average completion time for each
phase and the total division time can be estimated with relatively
high precision.
To better quantify the uncertainty of these estimates, Bayesian
99% credibility regions (CR) were computed by the Markov chain
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Figure 4. Dual pulse protocol. A: Simplified schematic representa-
tions of the protocols corresponding to a conventional single pulse
labelling with one nucleoside analog (e.g., BrdU) and a dual pulse
labelling experiment with two different nucleoside analogs (e.g., BrdU
together IdU or EdU). B: Artificial staining of single-pulse labelling data
(for original data see Fig. 2), showing eight of the nine subpopulations
that could potentially be identified with double-pulse labelling. Notice
that the four population f lu, f ld , fuG1 and f
u
G2M
that can be followed by
the conventional protocol, have each been subdivided according to the
cell cycle phases. The naming convention for the populations is as
follows: the superscript (lu= ‘labelled undivided’, ld = ‘labelled divided’,
u= ‘unlabelled’) indicates whether the population is labelled and
whether it has divided since the time of the first pulse; the first and
the second subscript (G1, S, G2M) stand for the phase in which the
population was at the time of the first and the second pulse
respectively. Double subscripts are used only when necessary.
doi:10.1371/journal.pcbi.1003616.g004
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Monte Carlo method (MCMC) using the same likelihood function
as before (Fig 3 C). CRs followed mainly the same trends as the
regions observed in the ML estimates, covered however as
expected a larger volume. An exception was the ‘blown up’ CR
of the S phase parameter for the U87 cell line, for which the ML
estimates wrongly insinuated a well defined point estimate.
In Table 1 we summarized the obtained Bayesian summary
statistics. One can see that the intervals for the average duration of
each phase azb are narrow compared to those for the individual
parameters a and b. In both cases the data allows for a
deterministic S phase (a~0), while for the U87 data set variability
in G2M is a necessary characteristic to reproduce accurately the
data. Notably, when contrasting the two cell lines, are the short G1
phase of Chinese hamster cells and the approximately two times
more extended G2M phase of the human glioblastoma cell line. It
is out of the scope of this paper to interpret or relate these
differences to cell line specific conditions. More importantly in this
context is the fact that the information of the analyzed data is too
sparse to narrow down all the parameter values even under noise-
free conditions.
Redesigned dual pulse-labelling assay
The information extracted from the U87 and V79 data sets is
apparently insufficient to pinpoint all six parameters related to the
three phases of our simple cell cycle model. This is disappointing
especially because the number of support points largely exceeds
the three ideally required, and the support points seem to include
at least for the U87 data set one at t~0, a second at
0vtvmin (b) and a third at twmax (b):
A potential explanation for this poor resolution in the estimates
is the previously mentioned intermixing of the cell population
clusters in the BrdU versus DAPI scatter plots compared to the
ideal conditions discussed earlier. The cluster overlap in the data
makes it impossible to measure directly the frequencies of most of
the populations, including the cell cohorts described by Eq. 24.
In order to approach the conditions assumed in the thought
experiment by avoiding the loss of information caused by the
intermixing, we devised an extension of the current single pulse
protocol, which places a second pulse immediately before
measuring or fixing each sample (see Fig. 4, top). The second
pulse is expected to expose the cells with a further nucleoside
analog that can be distinguished from the first one by FACS:
Depending on the cell cycle kinetics and the length of the
measuring period, the additional pulse increases the number of
classifiable populations from four up to nine distinct populations.
To appreciate the additional populations identified by double
pulse labelling, data from a single pulse-chase labelling experiment
was artificially colored, to mimic the expected FACS output from
proliferating cells labelled according to the protocol described
before. In Fig. 4, besides the gates defining the populations f lu, f ld ,
fuG1 and f
u
G2M
, cells that have incorporated the second label are
drawn in red. For the time immediately after the pulse (i.e., t~0),
no extra information is gained by the second pulse. However,
already two hours later, one additional population can be
discerned. Twelve hours after the first pulse, seven population,
instead of three, can be recognized. Thus by resolving the four
initial population according to the cell cycle phases, it is possible to
measure the kinetics of nine subpopulations (f lu?ff luS ,f luG2Mg,
f ld?ff ldG1 , f ldS , f ldG2Mg, fuG1?ffuG1,G1, fuG1,S, fuG1,G2Mg, and
fuG2M?ffuG2Mg). Because all these kinetics depend on the cell
cycle parameters, each of them can in principle tell us something
about the phase completions times. However some information is
redundant. For example if f luS and f
ld
S are measured, then f
u
G1,S is
defined by the total fraction of cells in S phase, because
nS~f
lu
Szf
lu
Szf
u
G1,S: Similarly from f
lu
G2M
, f ldG2M one can deduce
fuG1,G2Mzf
u
G2M
, by knowing the frequency of cells in G2M phase.
Double-label experiments using pairs of nucleoside analogs like
BrdU, IdU and EdU, also in combination with radioactive
tritiated thymidine (½3H), have been explored in several cancer
cell proliferation studies [19,28–31]. In recent years, dual pulse
experiments using BrdU in combination with EdU have become
more common. Studies relying on this method estimated changes
in DNA replication, inferred mitochondrial DNA bio-genesis and
stained proliferating cells in the bone marrow in vivo [32–34], in
general with the aim to increase the statistical power of the
conventional methods.
To assess if the latter method would allow quantifying more
accurately and precisely the parameters of the model, we
generated in silico data mimicking the output of a hypothetical
dual pulse experiment using Eq. 24 and Eq. 25 (see Fig. 5 A). We
found that by employing the redesigned protocol with the same
replicates and time points as in the corresponding data sets, we
could reduce the regions corresponding to the ML up to point
Figure 5. Analysis of simulated dual pulse labelling data. A:
Average kinetics of unlabelled (dashed line) and labelled cell
cohorts (colored lines) were computed from Eq. 25, using ML para-
meter est imates from the U87 and the V79 data sets
(U87: a~f7:1,3:9,3:6g, b~f1:9,4:1,2:1g, V79: a~f1:4,2:3,0:5g, b~
f1:4,6:5,2:0g, units are hours). Support points and repeats were chosen
according to the real experiments. Multinomial noise was added,
mimicking the residuals found in the original data sets (see the
Computational Methods section for more details). Finally, model
solutions (lines) were fitted to the synthetic data sets (triangles).
Best fit parameters (U87: a~f7:5,3:2,4:5g, b~f1:7,5:3,2:0g, V79:
a~f1:2,2:5,0:4g, b~f1:4,6:2,2:1g, units are hours) B: ML parameter
estimates from simulated data. All ML regions converge to point
estimates (arrows). Squares indicate parameters used for generating the
data (see A). C: Bayesian bi-variate 99%-credibility regions for the
parameters a and b for each phase, based on the artificial data.
doi:10.1371/journal.pcbi.1003616.g005
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estimates (Fig. 5 B). Furthermore, the uncertainties due to noise
became also significantly smaller (Fig. 5 C). Pooling this artificial
data according to the output expected from a single pulse
experiment, reproduced again the uncertainties seen in Fig. 3 C
(not shown). Together this indicates that the redesigned dual pulse
protocol provides parameter estimates with higher accuracy and
precision. Real dual pulse labelling experiments will however be
needed to confirm these theoretical predictions.
Robustness of the estimates to other probability
distributions of the phase completion times and to
concurrent cell loss
The cell cycle model introduced here is deliberately simple and
neglects cell loss. In this section, we ask whether the estimates of its
parameters are reasonable when some of the simplifying assump-
tions of the model do not hold. Specifically, we ask how accurate
are the mean and standard deviation of the phase completion
times estimated using this simple model if the true completion
times were not distributed as a delayed exponential function or if
there was concurrent phase-specific cell loss.
Empirical measurements [35] indicate that the cycle phase time
for the S phase is distributed closer to a delayed hypoexponential
or a delayed gamma distribution (see below) rather than the
caricatural delayed exponential. Therefore, an important question
which arises is how much do the estimates of the average and
standard deviation in phase durations obtained with this simple
model depend on the true underlying distribution? While many
different scenarios could be tested we opted to fit a delayed
hypoexponential density with two decay and one delay parameter
to direct in vitro measurements of G1 and S phase durations
employing fluorescent biosensors (Fig. 6 A-B, [35]). Using the
obtained best-fit estimates, we then performed in silico dual-pulse
labelling experiments, in which the phase durations were drawn in
the case of the S and G1 phase from delayed hypoexponential
density functions (Fig. 6 C). Finally we fitted the simple model, i.e.,
Eq. 24 and Eq. 25, which is based on delayed exponential
distributions, to this data, to see if we could recover the original
averages and standard deviations despite using the ‘wrong’
caricatural model. Both summary statistics (i.e., mean, standard
deviation) of phase durations could successfully be re-estimated
(Fig. 6 D). Although generalizing this finding lies out of the scope
of this article, it suggests that even if the true underlying
distribution is not a delayed-exponential function, important
quantities like the average and standard deviation of the phase
durations may still be estimated with the simple model developed
herein. It also indicates that BrdU labelling experiments with a
realistic number of samples are unlikely to have the power to
discriminate between delayed exponential and more complex
density distributions.
We now turn to the issue of how much the presence of phase-
specific cell death (or loss in general), which is unaccounted for in
our model, affects the accuracy of the estimates of the mean and
standard deviation of the phase durations. To this end, we will first
introduce the extensions necessary to describe cell death in the
model. We rely on the fact that if the probability of death per cell
cycle is less that 50%, the average population size will
asymptotically grow exponentially with an effective growth rate
n, where 0vnvm: This implies that the arguments used to analyze
exponential growth without death remain valid for a model that
allows moderate levels of cell death.
Figure 6. Robustness of parameter estimates to empirical phase duration distributions that are not delayed exponential functions.
A-B: Least-squares fitting of histograms predicted from a hypoexponential distribution with two decay and one delay parameter fa0,a1,bg to
measurements of phase durations using fluorescent biosensors [35]. The number of cells that were tracked in the original study was around 15 cells.
C: Best fit of the cell cycle model with delayed exponential completion time distribution densities to synthetic data generated from a model with
hypoexponential completion time distribution densities for the G1 and S phase with parameters as in A and B. D: Recovery of the initial distribution
densities (solid lines) using the delayed exponential model (dashed line). Both the average and the variability in the S phase completion time
distribution (original average: 10.70 h, estimated average: 10.88 h; original std: 2.03 h, estimated std: 1.99 h) were estimated accurately. The data
shown in A-B was read from the graphs in the original publication ([35]).
doi:10.1371/journal.pcbi.1003616.g006
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To consider death, we assume that cells have two possible fates
per phase, either they progress to the next phase or they die. Let
ft(t), as before, be the phase completion time density, conditioned
however on the cell being alive at time t: And let fd(t) be the
phase-specific time to death density conditioned on the cell having
not progressed to the next phase. Then, as e.g., in [36], assuming
that both events compete with each other (i.e., whatever fate
happens first, prevents the other), the resulting density f(t,d)(t)
becomes
f(t,d)(t)~ftRd(t)zfdRt(t): ð28Þ
Consider now a scenario of an exponentially growing popula-
tion, in which cell death occurs exclusively during phase o: Let us
assume further that the o{phase specific time to death density
fdo (t) is a simple exponential density with mean r: Using straight-
forward probabilistic arguments, we can compute analytically, for
this simple scenario two important quantities, namely the
probability to die in this phase (pdo ), and the expected value of
the effective completion time, distributed as f(t,d)(t): We get
pdo~
ð?
0
fdo (x)Rto (x)dx~1{
r
rzao
 
e{bo=r, E½f(t,d)(t)~rpdo :
Note that, in this simple case, pdo is also the probability to die
per division cycle.
Evaluating Eq. 18 using f(to, do) instead of fto , we obtain for Eq.
24,
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where md and n
o
d represent the equivalents of m and n
o, we had
previously defined for the case of no cell loss. The former
quantities, which now depend on ro, are derived applying to Eq. 5
the same substitution as above. Expressions equivalent to Eq. 10
and Eq. 11 are obtained along the same lines. These become
however rather lengthy and are therefore omitted here. Eq. 29
reproduces accurately f luS in simulated BrdU pulse labelling
experiments, if death occurs, as specified above (see Fig. 7 A for
an example with o~S and pdS[ 0:0,0:3f g). The differences
between the analytical predictions for f luS with 30% death and
without death (denoted by Df luS ) are, for the parameter sets that we
tested, relatively small, and vanish as expected, as pdS tends to zero
(see Fig. 7 B for Df luS computed at one specific time point (t~4 h)
for different values of pdS ).
To further test, how much both cell death and a completion
time with a shape distinct from a delayed exponential may jointly
affect parameter estimates, we simulated BrdU pulse labelling
experiments, where two major assumptions underlying Eq. 24
were simultaneously violated. First, we assumed a delayed gamma
distribution (with shape parameter of two) for the completion time
of each phase. Second, we considered cell death during S phase,
and adjusted rS, such that pdS was either zero or 0:3: The
population size (starting with five cells) took about twice as much
time to grow to a similar size for pdS~0:3 compared to a the
scenario without death (see Fig. 7 C, middle column, for five
independent simulations). In addition, the variability in the
population sizes between the simulations appeared higher for
increased death rates. In contrast, when estimating the mean and
variance of ftS by non-linear least squares fitting using Eq. 24, the
marked changes seen in the population kinetics where not
paralleled by changes in the estimates. Both the mean and the
variance were accurately determined in both cases (see Fig. 7 C,
right column). Taken together, this suggests, that the estimates for
the mean and variance of ftS using Eq. 24, at least for the
reasonable parameter values that we tested, are relatively robust to
simultaneous changes in the shape of the completion time, and
moderate levels of cell death.
Discussion
In this article, we propose a simple stochastic model that aims at
approximating the time it takes for a cell to accomplish the
sequential phases of the cell cycle, by defining the completion time
in each phase as a delayed exponential density distribution. At first
sight this might seem a gross oversimplification of all the processes
involved. However, when compared with experimental data, this
simplistic model performs surprisingly well.
While the observation that the model reproduces closely the
experimental time series has to be interpreted with care, we think
its success can be explained by the fact that the probability rule
captures simultaneously two important regimes of complex
biochemical processes that qualitatively differ in their completion
time distribution. As was shown recently by Bel et al. [37] the
completion time for a large class of complex theoretical
biochemical systems, including models for DNA synthesis and
repair, protein translation and molecular transport, simplify either
to deterministic or to exponentially distributed completion times,
with a very narrow transition between the two regimes depending
on the rate parameters. These are precisely the ‘ingredients’ of the
delayed exponential distribution. Under this light our model could
be naively interpreted as a sensor that measures approximately the
relative contribution of delay and decay processes in each of the
cell cycle phases. However, whereas delays connected in series
form again a delay, this is not true for decays. Sequentially coupled
decays form a process with hypoexponential distributed comple-
tion times with a shape similar to the frequency distribution of cell
cycle phase completion time reported in [35]. Thus a more flexible
model for the completion time of each phase could be a
hypoexponential distribution of the family that we are currently
using to model the total cell cycle length distribution (i.e., Eq. 3). If
instead, processes are not connected in an ordered series but
rather concurrent, the times for all the processes to complete is
dominated by the largest delay or the smallest decay parameter.
It is tempting to interpret the relative weight of constant delay
and exponential decay (i.e., the coefficient of variation) as a
measure of the precision of the processes regulating each phase,
which in turn might reflect a selective pressure on timing. Tighter
pressure might reduce the coefficient of variation, as our results
suggest for the S phase when compared to the remaining phases.
Yet, this might also reflect the conjunction of many parallel and
independent process such as replication forks whose number is
expected to increase the timing precision by the law of large
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numbers. In fact, the mean time and the variance of the S phase
are shorter in the early phase of the embryo when cells display a
higher number of replication forks in which the DNA polymerase
progresses at the same rate [38].
An important simplification of our model consists in the
assumption that cell loss by death, differentiation or immigration
is small compared to population wide division rates, such that we
can neglect it when fitting the model to experimental data. The
main reason to adopt this approach was simplicity and the fact
that the available data sets did hardly permit the determination of
the possibly large number of additional parameters. While for the
U87 LIFE/DEAD discrimination was performed, the markers
used for gating are specific for late stages of apoptosis or necrosis
typically after membrane integrity is lost and therefore do not
necessarily reflect the true fraction of dying cells. The fraction of
dead cells identified and excluded by this method was typically
low. In case that experimental conditions would however suggest
substantial cell loss, the model is flexible enough to be adapted
without major technical difficulties, along the lines of Eq. 28 and
Eq. 29. For instance, when the number of new-born cells equals
the number of dying cells, solving the model analytically turns out
to be easier, because m~0: And given that the apoptotic state (e.g.,
defined by Annexin-V staining) would be measured simultaneously
with nucleoside incorporation and DNA content, this could open
up the possibility to assess the duration of apoptosis in vivo. These
potential extensions not withstanding, it is reassuring that
considering concurrent phase-specific cell death of up 30% may
not change the estimates of the mean and standard deviation of
the phase completion time obtained using a caricatural model that
neglects cell death, as our results indicate.
Another fundamental abstraction of our model is that the
completion times for the cell cycle phases of a given cell are
uncorrelated, which also implies uncorrelated division times of
parental cells and siblings. Even though positive correlation in
division times between parental and daughter cells [10] and
between siblings [36] has been observed recently in vitro by direct
long-term microscopy of activated proliferating B cells, Schultze et
al. reported many years ago for in vivo murine crypt epithelial
cells the lack of correlation of completion times of a cell through
successive phases [31]. It remains to be shown experimentally how
much of the correlation or lack of correlation is due to cell type or
environment. In any case, it would be interesting to extend the
present model to include correlation in phase completion times.
The live cell biosensor-based fluorescent imaging strategy
exploited in [35] allows for direct quantification of the stochastic
timing of the cell cycle phases. It is worth comparing the estimates
of cell cycle phase-specific completion times obtained with this
direct method with those provided by the indirect pulse labelling
method. The mean S phase completion time was reported for the
lines NCI-H292 and HeLa cell line to be 8.2 and 8.4 hours
Figure 7. Effect of cell death and completion time distribution on parameter estimates. A: Comparison of analytical predictions (lines, Eq.
29) with simulated BrdU labelling experiment (squares). Cell death is assumed to occur exclusively during S phase with probability 0 (red) and 0.3
(blue) respectively. Only the f luS population is considered. Parameters: a~f2:5, 2:0, 1:5g, b~f1:0, 5:0, 0:5g, units are hours. B: Difference between
Eq. 29 (accounting for cell death) and Eq. 24 (neglecting cell death) at time t~4 h (see dashed line in A), as a function of pdS : C: BrdU labelling
experiments were simulated assuming gamma distributed phase completion times (red curve, graphs on left column) and cell death during S phase
with probability pdS~0 and pdS~0:3 (green curve, graphs on left column). The effective completion time f(t,d) (gray density plot, left column), the
population growth (middle column) and the estimation of the mean and the standard deviation of ft are shown for both cases. Approximate
confidence intervals for the estimates are computed as 1.96 times the standard error. Even though f(t,d) and the population growth are strongly
influenced by the value of pdS , both f
lu
S and the estimates extracted from f
lu
S are barely affected. The dashed lines in the middle column indicate the
time of the first pulse, which was chosen such that the average population was similar in both scenarios. Parameters for gamma distributed
completion time distribution of the three phases: shape: k~f2:0, 2:0, 2:0g, scale: h~f1:25, 1:0, 0:75g, delay: b~f1:0, 5:0, 0:5g:
doi:10.1371/journal.pcbi.1003616.g007
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respectively with standard deviation of 0.5 and 2.9 hours
(extracted from Fig.2 in [35]), which lie in the range of the
estimates we obtained, despite the different human cell lines that
have been analyzed (Table 1). In principle, pulse labelling with
nucleoside analogs can be used in vivo to quantify the stochasticity
of the cell cycle in anatomical places that are currently not feasible
to visualize by multiphoton microscopy, given that a sufficiently
large (over 1000) and representative sample of cells can be
harvested. Our method therefore provides, concerning the G1, S
and G2M phases, very similar information as these imaging
methods, yet it has a much wider application scope.
In comparison with the Smith and Martin cell cycle model, that
assumes a single variable phase [5], we have proposed a more
complex model with three variable phases. A question can be
raised whether a less complex model with variability in only one or
two of the three phases would reproduce equally well our BrdU
pulse labelling data. This could simplify the analysis and reduce
the issue of parameter identification. One might, for example,
consider a scenario, similar to the double transition probability
model analyzed in [39], in which the G1 and the G2 phase have
delayed exponentially distributed durations, while the durations of
S and M phase are fixed. It is easy to see that such a less complex
model is embedded into our model, as it suffices to set aS~0,
while assuming that the variability in the duration of the G2M
phase is generated entirely during the G2 phase. Clearly, from a
data fitting perspective, and especially for the V79 data set, the
simpler embedded model and the larger model would perform
equally well. This can be read directly from Fig. 3, as the set of
approximate ML estimates for aS includes values that are equal or
close to zero. However, the interpretation of the V79 data set
based on these two models would be fundamentally different. For
instance, by relying on the deterministic model, one would be lead
to conclude that the S phase duration is for every cell about
9 hours. By allowing however for aS§0, possible interpretations
of the data encompass the latter case, but in addition include
scenarios in which some cells complete their S phase in about
7 hours, while other cells may take far longer. Even though the
original data does not permit to discriminate between these
models, simulated dual pulse labelling experiments indicate that
this is in principle feasible. Finally, in view of the experimental
data provided by Hahn et al. ([35], used in Fig. 6 B), the scenario
of variable S-phase duration with aS§0 is well justified.
On the other hand, we distinguished only three cell cycle
phases, although the cell cycle is typically structured into at least
four biologically distinct phases. This simplification stems from the
fact that quantification of DNA content by flow cytometry cannot
discriminate between cells in the G2 and M phase. Additional
biomarkers, such as pS780 reported by Jaccoberger et al [40],
could be used together with DNA content dyes and nucleoside
analogs in extended labelling protocols to identify the four main
cell cycle phases. Extending the model to distinguish accordingly a
fourth phase would be rather straightforward mathematically.
Despite restricting the model to three phases, it is worth noticing
that we are extending the work of Cain and Chau [39,41], who
studied both balanced and non-balanced growth conditions,
assuming one and two random transitions, mapped respectively
to part of G1 and the remaining cell cycle phases. Also, we extend
the work of Larsson et al. [42] who were able to infer the variation
in the completion times of S and G2 based on the histograms of
DNA content.
Long-term labelling with BrdU has been used in vivo to study
disease progression of infected rhesus macaques with the simian
immunodeficiency virus [1,43] and due to toxicity more rarely in
HIV-1 [44]. These studies typically targeted turnover rates of T
lymphocytes subpopulation over a time period of several weeks
and provided average birth and death rate estimates. In contrast,
the method outlined here measures cell proliferation at a much
short timescale (12{24 hours) and has the potential to yield
phase specific estimates of both the average and the variability of
completion times. We anticipate that valuable complementary
information about SIV and HIV infection could be gained using
the redesigned protocol proposed here, especially in the light of the
known modulation of the cell cycle checkpoints by accessory viral
proteins [45].
Recently, in a computational ‘tour de force’, Falcetta et al.
[25] used a stochastic model of cell cycle progression with
discrete age-structure to derive qualitative conclusions about the
mechanism of action of several anti-cancer therapies. This
model was able to mimic (in their wording ‘rendering’)
quantitative data on single BrdU pulse labelling assay and
time-lapse imaging. The empirical distribution cell cycle lengths
they reported is akin to the hypoexponential family in our
model, however, the distributions of phase lengths remain
implicit in their simulation framework, in which time is discrete
and the parameters are transition probabilities per time step.
This prevents knowing how uncertain are the estimates of the
phase length variances based on single pulse labelling using their
approach.
Dual pulse labelling with a pair of thymidine analogs has been
used before to study cell cycle kinetics [19,28,31]. What is
common to those studies is scheduling the two consecutive pulses
by fixing the time lapse between the pulses, irrespectively of the
time at which cell samples are collected for cell cycle phase
analysis. It is worth stressing that, according to the present study,
specially when the second pulse is timed according to each
individual sample (i.e. adjusting accordingly the interval between
pulses) one can harness the potential of the model to quantify the
mean and variance of the phase-specific time. Making the second
pulse at a fixed minimal time before collecting cells for analysis
allows to resolve cellular cohorts, which would otherwise be
confounded.
New technologies like the one developed by Hahn et al. [35] but
also the ubiquitination-based cell cycle indicator, termed ‘Fucci’
[46] will greatly increase our understanding of phase resolved cell
cycle progression and unveil its epigenetic and stochastic
variability in isogenic cell populations. To translate this knowledge
gained mainly from in vitro cell cultures into an in vivo context,
long term (greater than 12 hours) and continuous multi-photon
imaging may be required. This however is technically very
demanding, and may remain prohibitive for cells deep inside
tissues despite major technological advances in the field. The
methodology presented here allows to measure phase specific cell
cycle progression variability in vivo by relatively simple technical
means. Even though nucleoside analogs are potentially carcino-
genic, the adverse effects of low dose pulse labelling remain
typically undetectable. Determining accurately cell cycle progres-
sion variability in mouse models of cancer might become a crucial
step in understanding the high variability in susceptibility to cell
cycle specific anti-cancer drugs.
Materials and Methods
Stability analysis
Here we will show that a cell population that follows the
stochastic model specified before will eventually enter a stationary
exponential growth phase. The requirement for such an asymp-
totic behavior is, recalling Eq. 11, that the complex valued
function
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Q(m)~2{P
i
(ebimzaime
bim) ð30Þ
has for positive valued elements of the vectors a and b a unique
positive real root which represents the upper bound of the real part
of any of its other potentially infinite number of roots. The
complex numbers m that solve Eq. 30 correspond, according to our
model, to the stationary phase growth rate of the proliferating cell
population. In case that m is real, the population is growing
exponentially, while if m is purely imaginary growth is oscillating.
In general, roots have both non-zero real and imaginary parts,
which leads to oscillations with growing or decaying amplitude. If
for real x and y we write m~xziy the real and imaginary part of
Q(m) are computed as
Re(Q)~2{eBx y1 cos (By){y2 sin (By)ð Þ,
Im(Q)~{eBx y2 cos (By)zy1 sin (By)ð Þ, ð31Þ
where
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For m to be a root of Q, both real and imaginary part have to
vanish.We restrict our analysis to the positive complex half
plane, i.e. x§0, since we are interested in growing and
not contracting cell populations. Due to the symmetries
in the trigonometric functions sin ({y)~{ sin (y) and
cos({y)~cos(y) and y1({y)~y1(y) and y2({y)~{y2(y)
one can easily see that if m~xziy is a root, its complement
m~x{iy is also a root. We can thus reduce the analysis even
further to values with positive imaginary parts. If for fixed x we
plot Q in the complex plane as a parametric function of y[½0,?
we get a spiral with the distance from a center point c~2zi 0
given by
r~
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
Re(Q){2ð Þ2zIm(Q)2
q
,
~eBx
ﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃﬃ
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r
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Crucially, as r is a monotone increasing function of y, the spiral
never crosses itself. For y~0 the imaginary part of Q vanishes as
expected because limy?0 sin (wy)~0 and limy?0 y2~0: For this
special case Re(Q)~2{Pi (ebimzaimebim) is obviously mono-
tone decreasing with x and restricted to the interval ½1,{?: This
means that the spiral can only ‘start’ in the interval between one
and minus infinity. Taken together, this implies that if for y~0
and fixed x, the real part of Q is positive, then there exist a single
‘opportunity’ to cross the origin, while if negative there exists none.
At the border where the real part is zero (Fig. 8 C), the
corresponding value of x is the only positive real root. Due to the
monotonicity of Re(Q) any value of x greater than the positive
real root will result for y~0 in Re(Q)v0 which does not admit for
any solution. The different possible scenarios are exemplified in
Fig. 8.
Experimental methods
Cell culture. Human astrocytoma cells U-87 MG (ATCC-
LGC) were routinely cultured with Dulbecco’s modified Eagles
medium (DMEM, Biochrom AG) supplemented with non-
essential amino acids (NEAA, Invitrogen GmbH), heat-inactivated
fetal bovine serum (FBS, 10%, Biochrom AG) and additives
(penicillin-streptomycin-glutamine, Invitrogen GmbH) in plastic
flasks (TPP AG) at 37uC in 5% CO2-humified incubators and were
passaged twice a week using Dulbecco’s PBS (DPBS, Apotheke
Innenstadt Uni Mnchen) and Trypsin/EDTA (Biochrom AG)
before reaching confluence.
Figure 8. Stability analysis. Q(xziy) as a function of y§0 for fixed
values of x§0: For y~0 (green circle) the real part of Q takes,
depending on x[½0,?, a value in the interval ½1,{?: The values for x
are increasing from A-D, while a and b remain unchanged. For relatively
low values of x (A-B) the real part Re(Q) is positive for y~0: After one
or several turns, i.e by increasing y the spiral can potentially cross the
origin only once (empty circle). In A the spiral misses the origin, while in
B the spiral crosses the origin after one turn. Crossing of the origin
means that the corresponding complex number m~xziy is a root of Q.
In C the spiral starts at the origin. This represents the only real positive
root of Q. For initially negative values of Re(Q) (D) the spiral can never
cross the origin because the distance to the center point (gray circle) is
already in the beginning for y~0 larger than the distance between the
latter and the origin. By increasing y this distance will even grow further
according to Eq. 33.
doi:10.1371/journal.pcbi.1003616.g008
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Treatment with BrdU. For cell cycle analysis cells
(2.06104 cm22) were seeded in 75 cm2 culture flasks and
incubated for 24 h followed by the BrdU pulse. For this
purpose, medium was replaced by medium supplemented with
BrdU (10 mM, Bromodeoxyuridine, Becton Dickinson GmbH),
cells were incubated for 30 min at 37uC followed by washing
away of BrdU for two times with fresh medium. Cells were
then again incubated at 37uC for a designated period of time
(0 h, 2 h, 4 h, 6 h, 8 h, 12 h) to measure proliferation over
12 h.
Preparation of samples. Collecting of cells was performed
by trypsinization using DPBS, Trypsin/EDTA and medium
followed by washing of cells in DPBS. To exclude dead cells from
the analysis staining of dead cells was performed. For this purpose
cells were incubated for 30 min with fluorescent dye (LIVE/
DEAD Fixable Green Dead Cell Stain Kit, Invitrogen) according
to the manufacturers instructions followed by washing with DPBS.
Consequent steps of sample preparation were processed using the
APC BrdU Flow Kit (Becton Dickinson GmbH). Cells were
washed once with Perm/Wash Buffer and fixed for 30 min on ice
with Cytofix/Cytoperm Buffer. After washing with BD Perm/
Wash Buffer cells were resuspended in Cytoperm Plus Buffer and
incubated on ice for 10 min followed by washing with Perm/Wash
Buffer and incubation in Cytofix/Cytoperm Buffer for 5 min on
ice. Cells were then washed with Perm/Wash Buffer and
incubated with 2 M HCl-Triton (1%) for 30 min at room
temperature followed by washing twice with Perm/Wash Buffer.
For detection of incorporated BrdU cells were incubated with
diluted (1:50) fluorochrome-conjugated anti-BrdU antibody for
20 min at room temperature. Cells were then washed with BD
Perm/Wash Buffer and further incubated with DAPI (0.5 mg=ml
in staining buffer: 100 mM Tris, pH 7.4, 150 mM NaCl, 1 mM
CaCl2 0.5 mM MgCl2 0.1% Nonidet P-40) for 30 min at room
temperature. All samples have subsequently been stored on ice
until acquisition.
Acquisition and analysis. Acquisition of data was per-
formed by measuring fluorescence intensity using a BD LSR II
Cytometer at the excitation wavelength of 660 nm for APC and
450 nm for DAPI and the software BD FACSDiva.
Computational methods
Modeling and simulations. Anti-derivatives, equations as
well as eigenvalue problems were solved with the help of
Mathematica. Stochastic simulations, Markov chain Monte Carlo
and optimization algorithms (e.g. least square fitting and Newton-
Raphson root finding) were implemented in C++. To fit the
parameters of the model to the data we relied on the population
based covariance matrix adaptation evolution strategy provided by
the C++ library SHARK [47].
In silico data. In order to anticipate and compare the
information content in data sets that could potentially be acquired
according to the dual-pulse protocol, in silico data was generated.
The simulated data consisted of frequencies computed according to
our model using ML parameter estimates. Noise was added to the
frequencies by simulating a sampling process with replacement with
frequencies given by the model and a population size of 300 and 600
for the U87 and the V79 data set respectively. This reproduced
approximately the variability observed in the original data sets. To
make comparison with available data reasonable support points
were taken to be the same as in the respective data set.
Bayesian inference. When estimating, by FACS analysis,
frequencies of cells in different phases of the cell cycle,
measurement noise becomes unavoidable. Potential sources of
noise include variability in experimental conditions, gating errors,
stochasticity in cell division, FACS measurement errors, and many
more. Here we describe an attempt to account, in a simple way,
for the observed experimental noise by taking a Bayesian
approach. This provides us not only with maximum likelihood
estimate regions of the model parameter, but in addition will give
us an idea about the uncertainty that we have about the parameter
values.
Even though considering all potential sources of noise would be
most consistent, the resulting probability model would become far
more complex than our initial cell cycle model. To avoid this
overload we assume that a relatively simple ad hoc multivariate
probability density function approximates reasonably well the
average and the noise in the observed frequencies at a single time
point. This probability density function, which corresponds to the
likelihood Pi of a single measurement event ~ni, is defined by
Pi(~ni Da,b,N; ti)~C(N)P
k
j~1
~n
N|ni,j{1
i,j
C(N|ni,j)
, ð34Þ
where C is the Euler gamma function. The right-hand side of
Eq. 34 corresponds to a continuous approximation of a scaled
multinomial distribution with support xj[½0,1 and
P
xj~1 [48].
The parameter N, which determines the spread of the distribution,
can be interpreted as an effective population size. Taking e.g., a
sample of size N from a population of cells containing k sub-
populations with proportions given by ni yields frequencies with a
probability density approximately distributed accordingly. If N is
small the density distribution is broad, while if N becomes large
the density distribution becomes narrow.
Following in general terms the notation in the main text, the ~ni,j
denote the k measured population frequencies from experiment i
and the ni,j stand for the corresponding frequencies predicted by
the cell cycle model. The latter obviously depend on the parameter
vector a and b and the time ti:
Having defined the likelihood Pi for an outcome of a single
pulse labelling experiment, the likelihood for the outcomes of a set
of m experiments is the product P~Pmi~1 Pi under the
reasonable assumption that noise in a specific experiment is
independent of all the other experiments. By numerically inverting
P, using Bayes theorem, one can obtain the posterior and
subsequently the uncertainty over the model parameter given the
data, the model and prior knowledge.
To estimate the maximum likelihood regions, the posteriors and
the uncertainties in the a and b for the U87 and V79 data sets, we
implemented in C++ the adaptive Markov-Chain-Monte-Carlo
algorithm proposed in [49]. The estimates for the maximum
likelihood regions are obtained by fixing N to a very large value
(e.g., 105). For Bayesian inference, N was considered as an
additional parameter. For simplicity, improper priors uniformly
distributed over the positive real number were assumed for all
parameter. The first 106 steps of the initially 107 step-long chains
were discarded, and of the remaining chains every 10009th step
was included in the subsequent analysis. The credibility regions
were computed from the resulting MCMC chains using the
‘HPDregionplot’ routine in the R package ‘emdbook’, and
convergence of the chains were confirmed using the Gelman
convergence test.
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